Oncobesity News Posts
Side Effects of GLP-1 Drugs: What Doctors Should Know
Popular weight loss drugs have been linked to gastrointestinal, mental health, and vision problems, but the benefits appear to outweigh the risks. Medscape Medical News
Cancer-like mutations in healthy cells point to origins of breast cancer
Researchers have pinpointed what could be the early genetic origins of breast cancer — cancer-like mutations appearing in the cells of healthy women. In a new study, the international collaborators analyzed the genomes of more than 48,000 individual breast cells from women without cancer, using novel techniques for decoding the genes of single cells. While the vast majority of cells appeared normal, nearly all of the women harbored a small number of breast cells — about 3 per cent — that carried genetic alterations commonly associated with cancer. The findings suggest that these rare genetic anomalies may represent some of the earliest steps in a series of events that could culminate in breast cancer development.
Healthy women have cells that resemble breast cancer
A new study finds that, in healthy women, some breast cells that otherwise appear normal may contain chromosome abnormalities typically associated with invasive breast cancer. The findings question conventional thinking on the genetic origins of breast cancer, which could influence early cancer detection methods. The study discovered that at least 3% of normal cells from breast tissue in 49 healthy women contain a gain or loss of chromosomes, a condition known as aneuploidy, and that they expand and accumulate with age.
Healthy women have cells that resemble breast cancer, study finds
A new study from researchers at The University of Texas MD Anderson Cancer Center finds that, in healthy women, some breast cells that otherwise appear normal may contain chromosome abnormalities typically associated with invasive breast cancer. The findings question conventional thinking on the genetic origins of breast cancer, which could influence early cancer detection methods.
‘A Watershed Moment’: GLP-1 Drug Succeeds in Late-Stage MASH Trial
(MedPage Today) — Semaglutide (Wegovy) improved liver fibrosis in patients with metabolic dysfunction-associated steatohepatitis (MASH) and led to greater rates of MASH resolution, an interim analysis of a phase III trial showed.
In part 1 of…
American College of Surgeons Operative Standards and Breast Cancer Outcomes
This cohort study evaluates the potential association of the American College of Surgeons operative standards for cancer surgery with short-term oncologic outcomes in breast cancer.
Weight loss drug makers want more insurance plans to cover Wegovy and Zepbound
Weight-loss drug makers are directly targeting employers in a campaign to expand health insurance coverage of their popular, but pricey, medications.Read more…
GLP-1 Use Prior to Surgery: Analyzing the Updated Guidance
(MedPage Today) — Since the modern practice of anesthesia has evolved, providers have been concerned about pulmonary aspiration — when gastric contents enter the lung, resulting in severe complications including pneumonitis, and aspiration…
Novo semaglutide data in MASH could negatively impact Madrigal’s Rezdiffra
Post Content This post first appeared on Healthcare Articles on Seeking Alpha Want to know more about it? Read More
Cancer-like mutations in healthy cells point to genetic origins of breast cancer
Researchers at the University of British Columbia (UBC), BC Cancer, Harvard Medical School and Memorial Sloan Kettering Cancer Center (MSK) have pinpointed what could be the early genetic origins of breast cancer—cancer-like mutations appearing in the cells of healthy women.
#Visual Abstract: Semaglutide Imrpoves Weight Loss Gains and Pain Related to Knee Osteoarthritis in Patients with Obesity
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.
The post #Visual Abstract: Semaglutide Imrpoves Weight Loss Gains and Pain Related to Knee Osteoarthritis in Patients with Obesity first appeared on 2 Minute Medicine. Source: 2 Minute Medicine
Food Retention With GLP-1s May Vary by Endoscopic Procedure
A study found that GLP-1 RA use is linked to risks for retained gastric contents during single endoscopic procedures but not with combined upper endoscopy and colonoscopy. Medscape Medical News
Wondr Health Expands Weight Loss Program with Support for GLP-1 Users
What You Should Know: – Wondr Health, a leader in virtual metabolic health programs, has announced the expansion of its weight and obesity care solution, Wondr Plus. – The enhancement provides comprehensive lifestyle support and nutrition counseling for employees using GLP-1 weight-loss medications, addressing the challenges of medication adherence and side effects. Addressing the Need … Read More
Small Benefit, Persistent Toxic Risk With Adjuvant Anthracycline in Breast Cancer
(MedPage Today) — Adding an anthracycline to adjuvant chemotherapy for TOP2A-normal early breast cancer significantly improved disease-free survival (DFS) but not overall survival (OS) at 10 years, and doubled the risk of heart failure, a randomized…
Novo Nordisk semaglutide phase 3 trial for MASH meets primary endpoints
Post Content This post first appeared on Breaking News on Seeking Alpha Want to know more about it? Read More
Breast cancer drug blocked for NHS use in England and Wales after talks collapse
National Institute for Health and Care Excellence unable to reach price agreement with manufacturers of EnhertuA breast cancer charity has said it was “beyond devastated” that talks to make a life-extending drug available on the NHS to women with a terminal diagnosis have collapsed.The National Institute for Health and Care Excellence (Nice) said it had not been able to reach agreement with the makers of Enhertu so that it could approve its use in England and Wales. Continue reading…
Clinical study supports the anti-obesity effects of kimchi
Approximately 16% of the global population, or about 890 million people, suffer from obesity. The World Health Organization (WHO) has recognized obesity as a significant health issue and highlighted its impact on the quality of life and overall health of individuals across the world.
GLP-1RA and SGLT2 Inhibitor Prescribing in People With Diabetes
This pooled cross-sectional study explores prescribing rates for glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors among US patients with type 1 diabetes.
STAT+: Pharmalittle: We’re reading about a key Merck drug trial, cheap Wegovy in China, and more
Merck reported that a new formulation of Keytruda appears to deliver similar blood levels of the drug when given as a shot as when given intravenously
DR. MARC SIEGEL: Why Ozempic, Wegovy and other GLP-1s could be a magic shot against alcohol abuse
The COVID pandemic set in motion trends with alcohol use that have persisted. Disruptions in work, school and lifestyle have been linked to increased alcohol consumption.
CGM OK’d During Medical Imaging; All Semaglutide Doses Back; Bariatric Surgery Down
(MedPage Today) — Abbott’s FreeStyle Libre 2 and 3 are the first and only patient-applied continuous glucose monitoring (CGM) systems to be approved for use during medical imaging, the company said.
In related news, the American Diabetes Association…
More than half of US adults are now eligible for Ozempic, Wegovy
About 140 million Americans, more than half of the nation’s adults, could be considered candidates for weight loss drugs Ozempic and Wegovy, according to a new study from JAMA Cardiology. NBC medical contributor Dr. Natalie Azar breaks down the latest for TODAY.
When or Whether to Give Immunotherapy in Early Breast Cancer
Neoadjuvant immunotherapy offers a survival benefit in specific subtypes of patients but seems to offer no benefit in the adjuvant setting. Medscape Medical News
Pfizer, Arvinas delay late-stage trial for breast cancer therapy
Post Content This post firse appeared on Healthcare Articles on Seeking Alpha. Want to know more? Read More
More than half of U.S. adults could be candidates for Ozempic
More than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug semaglutide, a new analysis finds.
Will Ozempic Crush the Junk-Food Business?
As revolutionary new weight-loss drugs turn consumers off ultraprocessed foods, the industry is on the hunt for new products.
Diabetes meds metformin and GLP-1s can also curb asthma, research finds
Drugs already taken by millions of diabetes patients appear to also help slash asthma attacks by up to 70%, new British research shows.
Anti-obesity drugs, lifestyle interventions show cardiovascular benefits beyond weight loss
Popular anti-obesity drugs continue to show cardiovascular benefits beyond weight loss, according to several new papers published in JACC that are being simultaneously presented at the American Heart Association’s 2024 Scientific Sessions. JACC is publishing two secondary analyses on the impact of GLP-1 medications in improving cardiac structure and function in heart failure patients and cardiovascular outcomes in those who previously had cardiac bypass surgery, plus a new analysis of a lifestyle intervention trial showing that cardiac risk biomarkers change with weight loss.
Over 50% of U.S. Adults Qualify for Ozempic, Wegovy
(MedPage Today) — More than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated.
Among 25,531 participants in the National Health and Nutrition Examination Survey (NHANES) from 2015 to…
Tirzepatide yields sustained weight reduction in obesity and prediabetes, finds study
For patients with obesity and prediabetes, three years of tirzepatide yields substantial and sustained weight reduction and a reduced risk for progression to type 2 diabetes, according to a study published in the New England Journal of Medicine.
Ozempic: Best and Worst Thanksgiving Foods to Eat While Taking Weight Loss Drugs
Eating some of your favorite Thanksgiving foods while taking drugs like Ozempic and Wegovy may trigger or worsen uncomfortable side effects. The Good Brigade/Getty Images
Eating certain foods can exacerbate GI discomfort and other common side effects associated with GLP-1 weight loss drugs like Ozempic and Wegovy.
Navigating holiday meals can be challenging as they often include many of these foods, such as high fat, greasy, and sugary items.
Health experts say it’s essential to understand what foods might worsen the side effects of the medication so that you can approach the holiday with strategies to minimize severe discomfort.
Thanksgiving is a time for family, (parade) floats, and, let’s be honest, food.
“Thanksgiving is all about food, eating, and over-indulgence: Turkey, stuffing, sweet potatoes, and pumpkin pie,” says Chris McGowan, MD, a gastroenterologist, obesity medicine specialist, and the founder of True You Weight Loss. “For many, eating to the point of discomfort is the highlight of the holiday and a way of showing appreciation to the host and chef.”
But McGowan says that, for the hundreds of thousands of people taking GLP-1 weight loss medications like Ozempic, Wegovy, Mounjaro, or Zepbound, the eat-until-you’re-full-and-then-get-seconds approach may present physically painful challenges.
These medications are associated with common side effects like nausea and vomiting, which can intensify when a person consumes certain foods, including high fat, high-sugar items that are often front and center on Thanksgiving tables.
“As we approach the food-centric holiday season, it’s essential to understand which foods might worsen the side effects of anti-obesity medications,” McGowan says.
Healthline spoke with McGowan and other obesity medicine specialists, who shared their tips for which Thanksgiving foods are the least likely to trigger side effects and which ones are best to limit or avoid for people taking weight loss drugs.
How GLP-1 drugs can affect appetite and tolerance for certain foods
GLP-1 medications are a class of antiobesity and antidiabetic drugs, semaglutide (Ozempic and Wegovy) and tirzepatide (Zepbound and Mounjaro). They can help people lose significant weight, but they can also change how a person tolerates certain foods.
“GLP-1 medications mimic the GLP-1 hormone, which is produced in the small intestine. This hormone regulates blood sugar levels, appetite, and digestion,” says Michael L. Glickman, MD, a triple board certified family and obesity medicine physician who founded Revolution Medicine. “The medication helps with weight loss by slowing digestion and increasing satiety. This helps reduce food portions.”
Portions are generally large on Thanksgiving, but that’s not the only potential pitfall for people taking drugs like Ozempic.
“Thanksgiving favorites, which tend to be high in sugar, carbohydrates, and unhealthy fats, can be more likely to cause gastrointestinal issues when they stay in the stomach longer,” Glickman says.
GI issues, like nausea and vomiting, are common side effects associated with GLP-1 drugs, so consuming these foods can either trigger or worsen them, explains Mir Ali, MD, a board certified general surgeon, bariatric surgeon, and medical director of MemorialCare Surgical Weight Loss Center.
Thanksgiving foods to avoid on Ozempic, Wegovy, and similar drugs
First, it’s important to note that there is no specific “Ozempic diet,” and you can still enjoy all your favorite Thanksgiving dishes in moderation.
“It’s perfectly fine to enjoy all of Thanksgiving’s tastes and flavors, but be mindful of portions and keep the heavier foods to a minimum,” McGowan says.
Ali says greasy, fried, sugary, high carb, calorie-dense foods take a while to digest. Because of this, they may be more likely to trigger uncomfortable side effects.
According to McGowan, some Thanksgiving staples that fit this bill include:
Stuffing
Candied yams (often doused in butter, sugar, and marshmallows)
Green bean casserole (often heavy in cream and fried onions)
Mashed potatoes with gravy
Pecan pie
Canned cranberry sauce (often high in sugar)
Macaroni and cheese
Ali also advises people to be mindful of alcohol consumption.
“Alcohol contains a large amount of carbohydrate calories and can cause more nausea and reflux,” Ali says.
Ali also adds that foods affect people differently, so it’s critical to tune into your body.
Thanksgiving foods least likely to cause side effects on Ozempic, Wegovy
The holidays can feel emotionally nourishing — and they can be physically, too.
“For many, the holidays represent an important time for family and social gatherings and celebrations,” McGowan says. “It’s important to continue enjoying the season’s positive aspects without triggering troublesome or potentially dangerous medication side effects.”
Glickman suggests prioritizing foods like lean proteins, fiber, and non-starchy vegetables.
Glickman and McGowan said the meal’s star, the turkey, fits that bill if it’s roasted.
McGowan says some other foods include quintessential Thanksgiving menu items like:
Roast vegetables like oven-roasted carrots, parsnips, and Brussels sprouts
Homemade cranberry sauce using a recipe that minimizes sugar
Sauteed or steamed green beans
Tips for managing Thanksgiving while taking GLP-1 drugs like Ozempic
McGowan recommends taking time before Thanksgiving to reflect on details like the menu, guest list, location, and potential challenges.
“Anticipating these scenarios can help you stay in control and enjoy the day,” McGowan says.
The following simple tips can help you manage potential challenges during holiday meals.
Don’t skip meals
Glickman and McGowan say “saving” calories by ditching or severely limiting food intake ahead of a Thanksgiving meal is a common mistake for people trying to lose weight or maintain weight loss. It can backfire.
“Skipping meals will only lead to excessive hunger and overeating,” McGowan says.
Glickman suggests prioritizing breakfast on Thanksgiving morning.
“Start your day with a healthy high protein and fiber breakfast and lunch,” Glickman says. “This will prevent you from starting Thanksgiving dinner with 10/10 hunger and limit overeating.”
Bring a food you’re excited to eat
Food is more than fuel for the body — it’s about taste, socialization, and memories. Hearing about the foods you “can’t eat” or “can’t have much of” ahead of a food-centered holiday like Thanksgiving can feel like a downer, especially if you aren’t the host or handling the cooking.
McGowan says you can avoid this pain point by adding some favorite dishes to the Thanksgiving meal that you know you’ll enjoy from a taste and lack of side effect perspective.
Strategize the meal
Glickman recommends starting the meal by filling your plate with whole foods like veggies, whole grains, and lean proteins before adding smaller portions that can worsen GLP-1 side effects. Then, eat the nourishing foods that are less likely to cause discomfort first, like protein-rich roasted turkey and fiber-packed veggies.
“This will also help with satiety,” Glickman says.
Savor the meal
“Eating slower allows time for the sensation of fullness to become more apparent and helps avoid overeating,” Ali says.
McGowan says it also helps you enjoy the whole experience of the meal, including family, friends, and flavors.
Go for a post-meal walk
Glickman says heading out for a walk following a meal is useful.
“Going for a walk within 30 minutes of your Thanksgiving meal helps with motility, improves digestion, and limits insulin spikes,” Glickman says. “Walking after large meals can be a useful tip to help stay on track with your weight loss journey.”
Avoid leftovers
“Once-a-year” foods can become more than that because of leftovers.
“Keep Thanksgiving to one meal,” McGowan says. “If you are hosting, send your leftovers with guests. If you’re a guest, either decline the leftovers or take them home and toss them.”
Takeaway
If you’re taking a GLP-1 medication like Ozempic, Wegovy, Mounjaro, or Zepbound, eating certain foods can trigger common side effects such as nausea, bloating, and diarrhea.
Navigating holiday meals can be challenging as they often include many of these foods.
Health experts say it’s essential to understand what foods might worsen the side effects of the medication so that you can approach the holiday with strategies to minimize severe discomfort.
Experts say eating foods like lean proteins (including roasted turkey) and fiber-rich foods like roasted vegetables may be best to prioritize, while it’s a good idea to limit foods that are high in fat, carbs, and sugar.
Novo Nordisk reportedly launches Wegovy in China
Post Content This post first appeared on Healthcare Articles on Seeking Alpha Want to know more about it? Read More
Lilly, Incyclix to work on Verzenio combo treatment for breast cancer
Post Content This post firse appeared on Breaking News on Seeking Alpha. Want to know more? Read More
7 Foods And Drinks You Should Avoid While Taking Ozempic—And Why It Matters For Your Results
Post Content This post first appeared on Forbes Health Want to know more about it? Read More
Exenatide, a GLP-1 analog, by IV during cardiac surgery did not reduce organ injury or death
A large-scale clinical trial found that intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) analog medication, during heart surgeries involving bypass did not significantly reduce the risk of death, stroke or organ failure. Researchers presented this preliminary late-breaking science trial on Nov. 17 at the American Heart Association’s Scientific Sessions 2024. The meeting, held Nov. 16–18, 2024, in Chicago, is a premier global exchange of the latest scientific advancements, research and evidence-based clinical practice updates in cardiovascular science.
‘Staggeringly high’ discontinuation rates for GLP-1 drugs like Ozempic or Wegovy
The use of diabetes and weight-loss medications like Ozempic or Wegovy—called GLP-1 drugs—has exploded in recent years, with 12% of U.S. adults having used one despite the high cost, according to a June 2024 poll.
Tirzepatide lowered risk of worsening heart failure and CVD death for obese adults
In the international SUMMIT trial, adults with heart failure preserved ejection fraction (HFpEF) and obesity taking tirzepatide for up to 3 years had a reduced combined risk of worsening heart failure events and cardiovascular death, and improved health status and physical function in comparison to participants taking placebo, according to late-breaking science presented Nov. 16 at the American Heart Association’s Scientific Sessions 2024. The meeting, held Nov. 16–18, 2024, in Chicago, is a premier global exchange of the latest scientific advancements, research and evidence-based clinical practice updates in cardiovascular science.
AI analysis of immune cells can predict breast cancer prognosis
Researchers at Karolinska Institutet have investigated how well different AI models can predict the prognosis of triple-negative breast cancer by analyzing certain immune cells inside the tumor. The study, published in the journal eClinicalMedicine, is an important step toward using AI in cancer care to improve patient health.
STAT+: Novartis ramps up in radiopharma, and Eli Lilly adds Zepbound details
In today’s biotech news, Zepbound trial data, Regenxbio’s Duchenne muscular dystrophy treatment, and Intellia’s promising ATTR-CM results.
Eli Lilly’s tirzepatide cuts risk of worsening heart failure in HFpEF, obese patients
Post Content This post first appeared on Healthcare Articles on Seeking Alpha Want to know more about it? Read More